If It’s Okay for Mice, It’s Good Enough for People. Right?

Madhava Setty The U.S. Food and Drug Administration appears set to circumvent its own regulatory process in order to authorize Pfizer’s new bivalent COVID-19 vaccine that targets the Omicron BA.4 and BA.5 subvariants — without requiring clinical trials on humans. … Yes, it’s an unprecedented move by the FDA, but Dr. Ofer Levy, professor of […]